Elicio Therapeutics, Inc.ELTXNASDAQ
Loading
Year-over-year gross profit growth rate
Latest
-1.06%
↓ 101% vs avg
Percentile
P29
Within normal range
Streak
2 qtr
Consecutive declineDecelerating
Average
80.72%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -1.06% |
| Q3 2025 | 0.00% |
| Q2 2025 | 100.00% |
| Q1 2025 | 8.85% |
| Q4 2024 | -5.17% |
| Q3 2024 | 1.02% |
| Q2 2024 | -1.03% |
| Q1 2024 | -1.40% |
| Q4 2023 | 0.00% |
| Q3 2023 | 0.00% |
| Q2 2023 | 0.00% |
| Q1 2023 | 100.00% |
| Q4 2022 | 0.00% |
| Q3 2022 | 0.00% |
| Q2 2022 | -100.00% |
| Q1 2022 | -94.38% |
| Q4 2021 | 1934.19% |
| Q3 2021 | 272.16% |
| Q2 2021 | 0.00% |
| Q1 2021 | -100.00% |
| Q4 2020 | -44.67% |
| Q3 2020 | 49.56% |
| Q2 2020 | 0.00% |
| Q1 2020 | -100.00% |
| Q4 2019 | 0.00% |